Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

Antibody Drug Conjugates Differentiate Uptake and DNA Alkylation of Pyrrolobenzodiazepines in Tumors from Organs of Xenograft Mice

Yong Ma, S. Cyrus Khojasteh, Cornelis E.C.A. Hop, Hans K. Erickson, Andrew Polson, Thomas H. Pillow, Shang-Fan Yu, Hong Wang, Peter S. Dragovich and Donglu Zhang
Drug Metabolism and Disposition December 2016, 44 (12) 1958-1962; DOI: https://doi.org/10.1124/dmd.116.073031
Yong Ma
Drug Metabolism & Pharmacokinetics (Y.M., S.C.K., C.E.C.A.H., D.Z.), Discovery Chemistry (T.H.P., P.S.D.), Translational Oncology (A.P., S.-F.Y.), Protein Chemistry (H.K.E.), and Development Toxicology (H.W.), Genentech, South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Cyrus Khojasteh
Drug Metabolism & Pharmacokinetics (Y.M., S.C.K., C.E.C.A.H., D.Z.), Discovery Chemistry (T.H.P., P.S.D.), Translational Oncology (A.P., S.-F.Y.), Protein Chemistry (H.K.E.), and Development Toxicology (H.W.), Genentech, South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelis E.C.A. Hop
Drug Metabolism & Pharmacokinetics (Y.M., S.C.K., C.E.C.A.H., D.Z.), Discovery Chemistry (T.H.P., P.S.D.), Translational Oncology (A.P., S.-F.Y.), Protein Chemistry (H.K.E.), and Development Toxicology (H.W.), Genentech, South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans K. Erickson
Drug Metabolism & Pharmacokinetics (Y.M., S.C.K., C.E.C.A.H., D.Z.), Discovery Chemistry (T.H.P., P.S.D.), Translational Oncology (A.P., S.-F.Y.), Protein Chemistry (H.K.E.), and Development Toxicology (H.W.), Genentech, South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Polson
Drug Metabolism & Pharmacokinetics (Y.M., S.C.K., C.E.C.A.H., D.Z.), Discovery Chemistry (T.H.P., P.S.D.), Translational Oncology (A.P., S.-F.Y.), Protein Chemistry (H.K.E.), and Development Toxicology (H.W.), Genentech, South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas H. Pillow
Drug Metabolism & Pharmacokinetics (Y.M., S.C.K., C.E.C.A.H., D.Z.), Discovery Chemistry (T.H.P., P.S.D.), Translational Oncology (A.P., S.-F.Y.), Protein Chemistry (H.K.E.), and Development Toxicology (H.W.), Genentech, South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shang-Fan Yu
Drug Metabolism & Pharmacokinetics (Y.M., S.C.K., C.E.C.A.H., D.Z.), Discovery Chemistry (T.H.P., P.S.D.), Translational Oncology (A.P., S.-F.Y.), Protein Chemistry (H.K.E.), and Development Toxicology (H.W.), Genentech, South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Wang
Drug Metabolism & Pharmacokinetics (Y.M., S.C.K., C.E.C.A.H., D.Z.), Discovery Chemistry (T.H.P., P.S.D.), Translational Oncology (A.P., S.-F.Y.), Protein Chemistry (H.K.E.), and Development Toxicology (H.W.), Genentech, South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter S. Dragovich
Drug Metabolism & Pharmacokinetics (Y.M., S.C.K., C.E.C.A.H., D.Z.), Discovery Chemistry (T.H.P., P.S.D.), Translational Oncology (A.P., S.-F.Y.), Protein Chemistry (H.K.E.), and Development Toxicology (H.W.), Genentech, South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donglu Zhang
Drug Metabolism & Pharmacokinetics (Y.M., S.C.K., C.E.C.A.H., D.Z.), Discovery Chemistry (T.H.P., P.S.D.), Translational Oncology (A.P., S.-F.Y.), Protein Chemistry (H.K.E.), and Development Toxicology (H.W.), Genentech, South San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Pyrrolobenzodiazepine (PBD)-dimer is a DNA minor groove alkylator, and its CD22 THIOMAB antibody drug conjugate (ADC) demonstrated, through a disulfide linker, an efficacy in tumor reduction for more than 7 weeks with minimal body weight loss in xenograft mice after a single 0.5–1 mg/kg i.v. dose. The DNA alkylation was investigated here in tumors and healthy organs of mice to understand the sustained efficacy and tolerability. The experimental procedures included the collection of tumors and organ tissues of xenograft mice treated with the ADC followed by DNA isolation/hydrolysis/quantitation and payload recovery from reversible DNA alkylation. PBD-dimer formed a considerable amount of adducts with tissue DNA, representing approximately 98% (at 24 hours), and 99% (at 96 hours) of the total PBD-dimer in tumors, and 78–89% in liver and lung tissues, suggesting highly efficient covalent binding of the released PBD-dimer to tissue DNA. The amount of PBD-DNA adducts in tumor tissues was approximately 24-fold (at 24 hours) and 70-fold (at 96 hours) greater than the corresponding amount of adducts in liver and lung tissues. In addition, the DNA alkylation levels increased 3-fold to 4-fold from 24 to 96 hours in tumors [41/106 base pairs (bp) at 96 hours] but remained at the same level (1/106 bp) in livers and lungs. These results support the typical target-mediated cumulative uptake of ADC into tumors and payload release that offers an explanation for its sustained antitumor efficacy. In addition, the low level of DNA alkylation in normal tissues is consistent with the tolerability observed in mice.

Footnotes

    • Received August 8, 2016.
    • Accepted September 26, 2016.
  • dx.doi.org/10.1124/dmd.116.073031.

  • Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 44 (12)
Drug Metabolism and Disposition
Vol. 44, Issue 12
1 Dec 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antibody Drug Conjugates Differentiate Uptake and DNA Alkylation of Pyrrolobenzodiazepines in Tumors from Organs of Xenograft Mice
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

Mechanism of Action of ADC Carrying Pyrrolobenzodiazepine

Yong Ma, S. Cyrus Khojasteh, Cornelis E.C.A. Hop, Hans K. Erickson, Andrew Polson, Thomas H. Pillow, Shang-Fan Yu, Hong Wang, Peter S. Dragovich and Donglu Zhang
Drug Metabolism and Disposition December 1, 2016, 44 (12) 1958-1962; DOI: https://doi.org/10.1124/dmd.116.073031

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Rapid CommunicationShort Communication

Mechanism of Action of ADC Carrying Pyrrolobenzodiazepine

Yong Ma, S. Cyrus Khojasteh, Cornelis E.C.A. Hop, Hans K. Erickson, Andrew Polson, Thomas H. Pillow, Shang-Fan Yu, Hong Wang, Peter S. Dragovich and Donglu Zhang
Drug Metabolism and Disposition December 1, 2016, 44 (12) 1958-1962; DOI: https://doi.org/10.1124/dmd.116.073031
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Experimental
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communications

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics